235 related articles for article (PubMed ID: 22813746)
61. Microenvironmental control of cell fate decisions in mammary gland development and cancer.
Rauner G; Kuperwasser C
Dev Cell; 2021 Jul; 56(13):1875-1883. PubMed ID: 34256927
[TBL] [Abstract][Full Text] [Related]
62. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
[TBL] [Abstract][Full Text] [Related]
63. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
64. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.
Bouras T; Pal B; Vaillant F; Harburg G; Asselin-Labat ML; Oakes SR; Lindeman GJ; Visvader JE
Cell Stem Cell; 2008 Oct; 3(4):429-41. PubMed ID: 18940734
[TBL] [Abstract][Full Text] [Related]
65. Quantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migration.
Ye X; Zhang Y; He B; Meng Y; Li Y; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):15836-44. PubMed ID: 26884854
[TBL] [Abstract][Full Text] [Related]
66. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.
Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW
J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346
[TBL] [Abstract][Full Text] [Related]
67. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.
Askarian-Amiri ME; Crawford J; French JD; Smart CE; Smith MA; Clark MB; Ru K; Mercer TR; Thompson ER; Lakhani SR; Vargas AC; Campbell IG; Brown MA; Dinger ME; Mattick JS
RNA; 2011 May; 17(5):878-91. PubMed ID: 21460236
[TBL] [Abstract][Full Text] [Related]
68. FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Nestal de Moraes G; Delbue D; Silva KL; Robaina MC; Khongkow P; Gomes AR; Zona S; Crocamo S; Mencalha AL; Magalhães LM; Lam EW; Maia RC
Cell Signal; 2015 Dec; 27(12):2496-505. PubMed ID: 26404623
[TBL] [Abstract][Full Text] [Related]
69. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
70. Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.
Chand V; Pandey A; Kopanja D; Guzman G; Raychaudhuri P
Mol Cancer Res; 2019 May; 17(5):1063-1074. PubMed ID: 30814128
[TBL] [Abstract][Full Text] [Related]
71. IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.
Farabaugh SM; Litzenburger BC; Elangovan A; Pecar G; Walheim L; Atkinson JM; Lee AV
Dev Biol; 2020 Jul; 463(1):77-87. PubMed ID: 32376245
[TBL] [Abstract][Full Text] [Related]
72. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
[TBL] [Abstract][Full Text] [Related]
73. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
[TBL] [Abstract][Full Text] [Related]
74. Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells.
Park E; Gong EY; Romanelli MG; Lee K
Biochem Biophys Res Commun; 2012 May; 421(3):532-7. PubMed ID: 22521644
[TBL] [Abstract][Full Text] [Related]
75. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
76. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
[TBL] [Abstract][Full Text] [Related]
77. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
[TBL] [Abstract][Full Text] [Related]
78. Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.
Lee HJ; Hinshelwood RA; Bouras T; Gallego-Ortega D; Valdés-Mora F; Blazek K; Visvader JE; Clark SJ; Ormandy CJ
Stem Cells; 2011 Oct; 29(10):1611-9. PubMed ID: 21823211
[TBL] [Abstract][Full Text] [Related]
79. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
80. Induction of human epithelial stem/progenitor expansion by FOXM1.
Gemenetzidis E; Elena-Costea D; Parkinson EK; Waseem A; Wan H; Teh MT
Cancer Res; 2010 Nov; 70(22):9515-26. PubMed ID: 21062979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
